Enlicitide northern fragment 4
Enlicitide northern fragment 4 is a key intermediate obtained via the retrosynthetic disconnection of Enlicitide decanoate (HY-W1126955). Enlicitide northern fragment 4 participates in the protecting-group-free biocatalytic convergent assembly of Enlicitide decanoate, an oral macrocyclic peptide PCSK9 inhibitor. Enlicitide northern fragment 4 can be used for the synthesis of Enlicitide decanoate, thereby supporting research related to hypercholesterolemia.
For research use only. We do not sell to patients.
- CAS No.: 3115127-25-5
- Formula: C45H60FN7O16
- Molecular Weight:973.99
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3115127-25-5
-
Molecular Weight 973.99
-
Formula C45H60FN7O16
-
SMILES
OC(C(O)=O)=O.NCCCCCCN1C(C(C(C[C@H]2C([N@]3[C@@H]([C@](OCC(NCC4=CC=CC(C[C@@H](C(N2)=O)N)=C4)=O)([H])CC3)C(N[C@@H]([C@H](O)C)C(OC(C)C)=O)=O)=O)=C1)=C5)=CC=C5F.OC(C(O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Enlicitide northern fragment 4
- 3115127-25-5
- Enlicitide northern fragment4
- Enlicitide northern fragment-4
- Drug Intermediate
- macrocyclic tetrapeptide
- macrocyclic peptide
- transacylation
- biocatalytic cascade
- macrocyclic bicyclic diamine
- synthetic intermediate
- amino alcohol product
- 5-enzyme one-pot sequential cascade
- BlTEEng
- Inhibitor
- inhibitor
- inhibit